Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Acorda Therapeutics Inc (NASDAQ:ACOR)

20.70
Delayed Data
As of 3:59pm ET
 -0.30 / -1.43%
Today’s Change
16.40
Today|||52-Week Range
40.57
+10.11%
Year-to-Date

Today’s Trading

Previous close21.00
Today’s open20.90
Day’s range20.30 - 21.25
Volume776,759
Average volume (3 months)652,871
Market cap$968.4M
Dividend yield--
Data as of 3:59pm ET, 01/23/2017

Growth & Valuation

Earnings growth (last year)-40.48%
Earnings growth (this year)-80.90%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+22.71%
P/E ratioNM
Price/Sales3.79
Price/Book1.50

Competitors

 Today’s
change
Today’s
% change
INSMInsmed Inc+0.06+0.42%
XNCRXencor Inc-0.07-0.32%
AIMTAimmune Therapeutics...-0.25-1.33%
LOXOLoxo Oncology Inc-1.06-2.69%
Data as of 4:00pm ET, 01/23/2017

Financials

Next reporting dateFebruary 16, 2017
EPS forecast (this quarter)$0.08
Annual revenue (last year)$492.7M
Annual profit (last year)$11.1M
Net profit margin2.24%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief Financial &
Accounting Officer
David Lawrence
Corporate headquarters
Ardsley, New York

Forecasts


Search for Jobs